P3 Health Partners Inc reports results for the quarter ended December 31 - Earnings Summary
28/03/2025 04:00
P3 Health Partners Inc PIII.OQ reported a quarterly adjusted loss of 39 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -22 cents. The mean expectation of five analysts for the quarter was for a loss of 11 cents per share. Wall Street expected results to range from -17 cents to -2 cents per share. Revenue rose 6.9% to $370.69 million from a year ago; analysts expected $378.06 million. P3 Health Partners Inc's reported EPS for the quarter was a loss of 36 cents. The company reported a quarterly loss of $58.62 million. P3 Health Partners Inc shares had fallen by 20.8% this quarter. FORECAST CHANGES The mean earnings estimate of analysts was unchanged in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" Wall Street's median 12-month price target for P3 Health Partners Inc is $1.00 This summary was machine generated from LSEG data March 28 at 03:59 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Dec. 31 2024 | -0.11 | -0.39 | Missed |
| Sep. 30 2024 | -0.04 | -0.29 | Missed |
| Jun. 30 2024 | -0.05 | -0.09 | Missed |
| Mar. 31 2024 | -0.11 | -0.16 | Missed |
Recent news on P3 Health Partners
See all newsBrief: P3 Health Partners Entered SPA With Affiliates Of CPF Pursuant To Which To Issue Up To $70 Million Of Units In Multiple Tranches - SEC Filing
P3 Health Partners Inc reports results for the quarter ended June 30 - Earnings Summary
P3 Health Partners lifts 2026 adjusted EBITDA outlook amid structural improvements
P3 Health Partners Inc expected to post a loss of $1.89 a share - Earnings Preview
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:55 AM